Related Experiment Video
Updated: Aug 22, 2025

14:14
Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.9K
Circulating Tumor Cells in Colorectal Cancer: Detection Systems and Clinical Utility
József Petrik1, Donatella Verbanac1, Marija Fabijanec1
1Department of Medical Biochemistry and Hematology, Faculty of Pharmacy and Biochemistry, University of Zagreb, Ante Kovačića 1, 10000 Zagreb, Croatia.
International Journal of Molecular Sciences
|November 11, 2022
Summary
Circulating tumor cells (CTCs) and CTC clusters in blood aid early cancer detection and prognosis. Research focuses on CTC detection systems for clinical applications in colorectal cancer (CRC) patients.
Area of Science:
- Oncology
- Cancer Biology
- Molecular Diagnostics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- Metastasis to distant organs is the primary driver of CRC-related deaths.
- Tumor cell dissemination and hematogenous spread are key to metastasis formation.
Purpose of the Study:
- To review research on circulating tumor cells (CTCs) for colorectal cancer (CRC).
- To identify suitable detection systems for CTCs and CTC clusters.
- To assess the clinical applicability of CTC analysis in CRC patients.
Main Methods:
- Literature review of studies on CTCs and CTC clusters.
- Analysis of current and emerging CTC detection technologies.
- Evaluation of prognostic and diagnostic significance of CTCs in CRC.
Main Results:
- CTCs and CTC clusters are crucial indicators in early cancer detection.
- CTC analysis offers prognostic value for monitoring disease progression and chemotherapy response.
- Development of detection systems is advancing for potential clinical use in CRC.
Conclusions:
- CTC analysis holds significant potential for early detection and monitoring of colorectal cancer.
- Further research into robust detection systems is needed for widespread clinical application.
- CTCs represent a promising biomarker for personalized CRC management.

